Reports for BAUSCH HEALTH, CANADA INC.
Company Name
BAUSCH HEALTH, CANADA INC.
Totals |
||
Shortage reports |
346 |
|
| Actual shortage: | 11 (3%) | |
| Anticipated shortage: | 0 (0%) | |
| Avoided shortage: | 34 (10%) | |
| Resolved: | 301 (87%) | |
Discontinuation Reports |
13 |
|
| To be discontinued: | 1 (8%) | |
| Discontinued: | 12 (92%) | |
| Reversed: | 0 (0%) | |
Late reports |
96 (27%) |
|
Overdue reports |
2 (17%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| LODALIS | 625MG | TABLET | Resolved | 2023-01-11 | 2023-03-04 | 180700 |
| LODALIS | 625MG | TABLET | Resolved | 2024-01-25 | 2024-03-26 | 217261 |
| EDARBI | 40MG | TABLET | Resolved | 2019-06-21 | 2019-06-27 | 87192 |
| EDARBI | 40MG | TABLET | Resolved | 2019-09-10 | 2019-11-19 | 93519 |
| EDARBI | 40MG | TABLET | Resolved | 2020-01-10 | 2020-02-28 | 103031 |
| EDARBI | 40MG | TABLET | Resolved | 2020-04-01 | 2020-05-13 | 110370 |
| EDARBI | 80MG | TABLET | Resolved | 2019-09-10 | 2019-11-19 | 93523 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2018-03-02 | 2018-06-30 | 41543 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-06-12 | 2019-07-05 | 86505 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2019-10-10 | 2019-10-17 | 96014 |
| SUBLINOX | 5MG | TABLET (ORALLY DISINTEGRATING) | Resolved | 2021-10-05 | 2021-12-09 | 146697 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2018-08-24 | 2019-01-23 | 58987 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2019-07-05 | 2019-08-14 | 88781 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2019-11-13 | 2020-01-23 | 98634 |
| EDARBYCLOR | 12.5MG 40MG | TABLET | Resolved | 2020-04-01 | 2020-04-24 | 110367 |
| EDARBYCLOR | 25MG 40MG | TABLET | Resolved | 2018-08-24 | 2018-11-09 | 58990 |
| EDARBYCLOR | 25MG 40MG | TABLET | Resolved | 2019-05-08 | 2019-11-19 | 83468 |
| EDARBYCLOR | 25MG 40MG | TABLET | Resolved | 2022-03-17 | 2022-04-07 | 156836 |
| XERESE | 5% 1% | CREAM | Resolved | 2017-03-17 | 2017-05-25 | 3303 |
| XERESE | 5% 1% | CREAM | Resolved | 2017-09-25 | 2018-02-13 | 23233 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| VITAMIN A ACID | 0.05% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217843 |
| DELATESTRYL | 200MG | SOLUTION | Discontinued | 2024-03-11 | 2024-04-26 | 221772 |
| VITAMIN A ACID | 0.025% | GEL | Discontinued | 2024-01-30 | 2024-02-08 | 217848 |
| THEOLAIR | 80MG | SOLUTION | Discontinued | 2021-04-26 | 2021-04-27 | 138081 |
| LIDEX | 0.05% | CREAM | Discontinued | 2023-12-08 | 2023-12-08 | 212804 |
| AIROMIR | 100MCG | METERED-DOSE AEROSOL | Discontinued | 2023-11-29 | 2023-11-29 | 211859 |
| ALTACE HCT | 12.5MG 2.5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214011 |
| ALTACE HCT | 12.5MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214014 |
| ALTACE HCT | 12.5MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214024 |
| ALTACE HCT | 25MG 5MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214017 |
| ALTACE HCT | 25MG 10MG | TABLET | Discontinued | 2023-12-21 | 2024-01-09 | 214027 |
| LODALIS | 3.75G | POWDER FOR SUSPENSION | Discontinued | 2023-12-08 | 2024-02-20 | 212799 |
| VITAMIN A ACID | 0.01% | GEL | To be discontinued | 2024-01-30 | 2024-01-30 | 217835 |
Showing 1 to 13 of 13